| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.006 |
| mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.007 |
| mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
-0.087 |
0.007 |
| mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.007 |
| mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.007 |
| mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.008 |
| mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.008 |
| mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
-0.09 |
0.008 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.008 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.008 |